Current Drug Development Overview: Targeting Voltage-Gated Calcium Channels for the Treatment of Pain

被引：8
作者：
Antunes, Flavia Tasmin Techera [1 ,2 ]
Campos, Maria Martha [3 ]
Ricardo Carvalho, Vanice de Paula [4 ]
da Silva Junior, Claudio Antonio [4 ]
Magno, Luiz Alexandre Viana [5 ]
de Souza, Alessandra Hubner [5 ]
Gomez, Marcus Vinicius [4 ]
机构：
[1] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada
[3] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Odontol, Escola Ciencias Saude & Vida, BR-90619900 Porto Alegre, RS, Brazil
[4] Fac Santa Casa BH, BR-30110005 Belo Horizonte, MG, Brazil
[5] Fac Ciencias Med Minas Gerais FCMMG, Programa Posgrad Ciencias Saude, BR-30110005 Belo Horizonte, MG, Brazil
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 11期
关键词：
analgesic; antinociception; calcium signaling; drug development; pain transmission; FAMILIAL HEMIPLEGIC MIGRAINE; CORTICAL SPREADING DEPRESSION; TRIAZOLE OXINDOLE TROX-1; HORN NEURONAL RESPONSES; DEPENDENT CA2+ CHANNELS; DORSAL-ROOT GANGLIA; RAT SENSORY NEURONS; DELIVERED N-TYPE; NEUROPATHIC PAIN; P/Q-TYPE;
D O I：
10.3390/ijms24119223
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Voltage-gated calcium channels (VGCCs) are targeted to treat pain conditions. Since the discovery of their relation to pain processing control, they are investigated to find new strategies for better pain control. This review provides an overview of naturally based and synthetic VGCC blockers, highlighting new evidence on the development of drugs focusing on the VGCC subtypes as well as mixed targets with pre-clinical and clinical analgesic effects.
引用
收藏
页数：17
相关论文
共 50 条
  • [41] Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders
    Heyes, Samuel
    Pratt, Wendy S.
    Rees, Elliott
    Dahimene, Shehrazade
    Ferron, Laurent
    Owen, Michael J.
    Dolphin, Annette C.
    PROGRESS IN NEUROBIOLOGY, 2015, 134 : 36 - 54
  • [42] Voltage-Gated Ion Channels in the PNS: Novel Therapies for Neuropathic Pain?
    Tibbs, Gareth R.
    Posson, David J.
    Goldstein, Peter A.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (07) : 522 - 542
  • [43] Calcium- and voltage-gated BK channels in vascular smooth muscle
    Alex M. Dopico
    Anna N. Bukiya
    Jonathan H. Jaggar
    Pflügers Archiv - European Journal of Physiology, 2018, 470 : 1271 - 1289
  • [44] Calcium- and voltage-gated BK channels in vascular smooth muscle
    Dopico, Alex M.
    Bukiya, Anna N.
    Jaggar, Jonathan H.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2018, 470 (09): : 1271 - 1289
  • [45] Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways
    Dongol, Yashad
    Cardoso, Fernanda C.
    Lewis, Richard J.
    TOXINS, 2019, 11 (11)
  • [46] Voltage-gated sodium channels and hyperalgesia
    Lai, J
    Porreca, F
    Hunter, JC
    Gold, MS
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 : 371 - 397
  • [47] Animal Venom Peptides Cause Antinociceptive Effects by Voltage-gated Calcium Channels Activity Blockage
    Trevisan, Gabriela
    Oliveira, Sara Marchesan
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (08) : 1579 - 1599
  • [48] Predicting functional effects of missense variants in voltage-gated sodium and calcium channels
    Heyne, Henrike O.
    Baez-Nieto, David
    Iqbal, Sumaiya
    Palmer, Duncan S.
    Brunklaus, Andreas
    May, Patrick
    Johannesen, Katrine M.
    Lauxmann, Stephan
    Lemke, Johannes R.
    Moller, Rikke S.
    Perez-Palma, Eduardo
    Scholl, Ute, I
    Syrbe, Steffen
    Lerche, Holger
    Lal, Dennis
    Campbell, Arthur J.
    Wang, Hao-Ran
    Pan, Jen
    Daly, Mark J.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (556)
  • [49] How voltage-gated calcium channels gate forms of homeostatic synaptic plasticity
    Frank, C. Andrew
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [50] The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases
    Cataldi, Mauro
    CURRENT NEUROPHARMACOLOGY, 2013, 11 (03) : 276 - 297
12345